Application
Fig1: Western blot analysis of ERK2 on different cell lysates using anti- ERK2 antibody at 1/2000 dilution.Positive control:Lane 1: JurkatLane 2:A431Lane 3: PC12Lane 4: NIH/3T3Lane 5: HelaLane 6: HT-29Lane 7: MCF-7
Application
Fig2: ICC staining of ERK2 in A549 cells (green). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.
Application
Fig3: Immunohistochemical analysis of paraffin-embedded human breast carcinoma tissue using anti-ERK2 antibody. Counter stained with hematoxylin.
Application
Fig4: Immunohistochemical analysis of paraffin-embedded human kidney tissue using anti-ERK2 antibody. Counter stained with hematoxylin.
Application
Fig5: Immunohistochemical analysis of paraffin-embedded mouse kidney tissue using anti-ERK2 antibody. Counter stained with hematoxylin.
Application
Fig6: Flow cytometric analysis of Hela?cells with SIRT1 antibody at 1/100 dilution (blue) compared with an unlabelled control (cells without incubation with primary antibody; red). Goat anti rabbit IgG (FITC) was used as the secondary antibody.